{"hideKeyline":true,"introText":"

Please find our answers to frequently asked shareholder questions below.

","introTitle":"FAQs","id":8133,"docCheckLogout":null,"pageType":"contentPage","languageCode":"en-GB","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-gb/","openInNewWindowText":null},{"text":"Investors","href":"/en-gb/investors/","openInNewWindowText":null},{"text":"Shareholder information","href":"/en-gb/investors/shareholder-information/","openInNewWindowText":null},{"text":"FAQs","href":"/en-gb/investors/shareholder-information/shareholder-faqs/","openInNewWindowText":null}]},"pageName":"FAQs","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-gb/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":true,"text":"Global"},"languageSelector":{"currentLanguage":null,"currentLanguageMobile":null,"selectableLanguages":[]},"darkModeSwitch":{"text":"Dark mode","tooltipText":"

Switch to dark mode to head towards a more sustainable world together. More info

"},"globalSiteLink":null,"locationSelector":{"text":"Change location","href":"/en-gb/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://www.gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-gb/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":true,"title":"Behind the Science magazine","url":"/en-gb/behind-the-science-magazine/","nodes":[],"isActive":false,"promos":[]},{"tooltip":null,"hasBorderRight":false,"title":"Company","url":"/en-gb/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-gb/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"GSK at a glance","url":"/en-gb/company/gsk-at-a-glance/","nodes":[],"isActive":false},{"title":"History and heritage","url":"/en-gb/company/history-and-heritage/","nodes":[],"isActive":false},{"title":"Board of Directors and Executive Committee","url":"/en-gb/company/board-of-directors-and-leadership-team/","nodes":[],"isActive":false},{"title":"Board information","url":"/en-gb/company/board-information/","nodes":[],"isActive":false},{"title":"Governance","url":"/en-gb/company/governance/","nodes":[{"title":"Committees","url":"/en-gb/company/governance/committees/","nodes":[],"isActive":false},{"title":"Shareholders","url":"/en-gb/company/governance/shareholders/","nodes":[],"isActive":false},{"title":"Sarbanes-Oxley Act 2002","url":"/en-gb/company/governance/sarbanes-oxley-act-2002/","nodes":[],"isActive":false},{"title":"Compliance","url":"/en-gb/company/governance/compliance/","nodes":[],"isActive":false}],"isActive":false},{"title":"Policy positions","url":"/en-gb/company/policy-positions/","nodes":[],"isActive":false},{"title":"Codes, standards and reports","url":"/en-gb/company/codes-standards-and-reports/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Our purpose, strategy and culture","image":{"src":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?rxy=0.56833333333333336,0.30177514792899407&width=329&height=185&format=webp&quality=100&v=1dba2ec0bc1e680","alt":"GSK Tech Human Image","darkModeSrc":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?rxy=0.56833333333333336,0.30177514792899407&width=329&height=185&format=webp&quality=50&v=1dba2ec0bc1e680"},"link":{"text":"FEATURED SECTION","href":"/en-gb/company/purpose-strategy-and-culture/","openInNewWindowText":null}},{"text":"Outstanding people","image":{"src":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=100&v=1dba2eba773f3d0","alt":"Angeles sitting on a sofa in a pink shirt","darkModeSrc":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=50&v=1dba2eba773f3d0"},"link":{"text":"FEATURED SECTION","href":"/en-gb/careers/outstanding-people/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-gb/innovation/","nodes":[{"title":"Our leading scientists","url":"/en-gb/innovation/our-leading-scientists/","nodes":[{"title":"Dr Tony Wood","url":"/en-gb/innovation/our-leading-scientists/tony-wood/","nodes":[],"isActive":false},{"title":"Dr Sabine Luik","url":"/en-gb/innovation/our-leading-scientists/sabine-luik/","nodes":[],"isActive":false},{"title":"Dr Hesham Ahmed Abdullah","url":"/en-gb/innovation/our-leading-scientists/hesham-abdullah/","nodes":[],"isActive":false},{"title":"Dr Kaivan Khavandi","url":"/en-gb/innovation/our-leading-scientists/kaivan-khavandi/","nodes":[],"isActive":false},{"title":"Dr Christopher Austin","url":"/en-gb/innovation/our-leading-scientists/dr-christopher-austin/","nodes":[],"isActive":false}],"isActive":false},{"title":"Research and development approach","url":"/en-gb/innovation/research-and-development-approach/","nodes":[],"isActive":false},{"title":"Pipeline","url":"/en-gb/innovation/pipeline/","nodes":[],"isActive":false},{"title":"Therapeutic areas","url":"/en-gb/innovation/therapeutic-areas/","nodes":[{"title":"Respiratory, immunology and inflammation","url":"/en-gb/innovation/therapeutic-areas/respiratory-immunology-and-inflammation/","nodes":[],"isActive":false},{"title":"Oncology","url":"/en-gb/innovation/therapeutic-areas/oncology/","nodes":[],"isActive":false},{"title":"HIV","url":"/en-gb/innovation/therapeutic-areas/hiv/","nodes":[],"isActive":false},{"title":"Infectious diseases","url":"/en-gb/innovation/therapeutic-areas/infectious-diseases/","nodes":[],"isActive":false}],"isActive":false},{"title":"Tech","url":"/en-gb/innovation/technologies/","nodes":[],"isActive":false},{"title":"Clinical trials at GSK","url":"/en-gb/innovation/trials/","nodes":[{"title":"Provision of unapproved medicines for unmet medical needs","url":"/en-gb/innovation/trials/provision-of-unlicensed-medicines-for-unmet-medical-needs/","nodes":[],"isActive":false},{"title":"Data transparency","url":"/en-gb/innovation/trials/data-transparency/","nodes":[],"isActive":false},{"title":"Representative clinical studies","url":"/en-gb/innovation/trials/representative-clinical-studies/","nodes":[],"isActive":false}],"isActive":false},{"title":"Partnering with GSK","url":"/en-gb/innovation/partnerships/","nodes":[{"title":"Supported studies","url":"/en-gb/innovation/partnerships/supported-studies/","nodes":[],"isActive":false}],"isActive":false},{"title":"R&D locations","url":"/en-gb/innovation/rd-locations/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Behind the science magazine","image":{"src":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebb585f130","alt":"Scientist works in a futurist vaccine laboratory for GSK","darkModeSrc":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebb585f130"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null}},{"text":"Our leading scientists","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=329&height=185&format=webp&quality=100&v=1dc651e856734f0","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=329&height=185&format=webp&quality=50&v=1dc651e856734f0"},"link":{"text":"Featured section","href":"/en-gb/innovation/our-leading-scientists/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-gb/products/","nodes":[{"title":"Product areas","url":"/en-gb/products/our-product-areas/","nodes":[],"isActive":false},{"title":"Products A-Z","url":"/en-gb/products/products-a-z/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Innovation","image":{"src":"/media/jxkd3fld/web03-header-stvg_2_2022_port_5_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe22d650","alt":"Lab technician leaning against wall","darkModeSrc":"/media/jxkd3fld/web03-header-stvg_2_2022_port_5_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe22d650"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/innovation/","openInNewWindowText":null}},{"text":"GSKPro for healthcare professionals ","image":{"src":"/media/xpibjmpq/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe35c210","alt":"Two scientists on orange background","darkModeSrc":"/media/xpibjmpq/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe35c210"},"link":{"text":"FEATURED WEBSITE","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":true,"title":"Responsibility","url":"/en-gb/responsibility/","nodes":[{"title":"Access","url":"/en-gb/responsibility/access/","nodes":[],"isActive":false},{"title":"Global health and health security","url":"/en-gb/responsibility/global-health-and-health-security/","nodes":[{"title":"Global health","url":"/en-gb/responsibility/global-health-and-health-security/global-health/","nodes":[],"isActive":false},{"title":"Health security","url":"/en-gb/responsibility/global-health-and-health-security/health-security/","nodes":[],"isActive":false},{"title":"Using our science for global health","url":"/en-gb/responsibility/global-health-and-health-security/using-our-science-for-global-health/","nodes":[],"isActive":false},{"title":"Improving access to healthcare","url":"/en-gb/responsibility/global-health-and-health-security/improving-access-to-healthcare/","nodes":[],"isActive":false},{"title":"Africa Open Lab","url":"/en-gb/responsibility/global-health-and-health-security/africa-open-lab/","nodes":[],"isActive":false}],"isActive":false},{"title":"Environment","url":"/en-gb/responsibility/environment/","nodes":[{"title":"Climate","url":"/en-gb/responsibility/environment/climate/","nodes":[],"isActive":false},{"title":"Freshwater","url":"/en-gb/responsibility/environment/freshwater/","nodes":[],"isActive":false},{"title":"Land","url":"/en-gb/responsibility/environment/land/","nodes":[],"isActive":false},{"title":"Oceans","url":"/en-gb/responsibility/environment/oceans/","nodes":[],"isActive":false},{"title":"Materials and waste","url":"/en-gb/responsibility/environment/materials-and-waste/","nodes":[],"isActive":false},{"title":"Health system sustainability","url":"/en-gb/responsibility/environment/health-system-sustainability/","nodes":[],"isActive":false}],"isActive":false},{"title":"Inclusion","url":"/en-gb/responsibility/inclusion/","nodes":[],"isActive":false},{"title":"Ethical standards","url":"/en-gb/responsibility/ethical-standards/","nodes":[{"title":"Working with third parties","url":"/en-gb/responsibility/ethical-standards/working-with-third-parties/","nodes":[],"isActive":false},{"title":"Public policy and patient advocacy","url":"/en-gb/responsibility/ethical-standards/public-policy-and-patient-advocacy/","nodes":[],"isActive":false},{"title":"Human rights","url":"/en-gb/responsibility/ethical-standards/human-rights/","nodes":[],"isActive":false},{"title":"Use of animals","url":"/en-gb/responsibility/ethical-standards/use-of-animals/","nodes":[],"isActive":false},{"title":"Engaging with healthcare professionals","url":"/en-gb/responsibility/ethical-standards/engaging-with-healthcare-professionals/","nodes":[],"isActive":false}],"isActive":false},{"title":"Product governance","url":"/en-gb/responsibility/product-governance/","nodes":[],"isActive":false},{"title":"Grants and donations","url":"/en-gb/responsibility/grants-and-donations/","nodes":[],"isActive":false},{"title":"Charitable investments ","url":"/en-gb/responsibility/charitable-investments/","nodes":[],"isActive":false},{"title":"Responsibility reports","url":"/en-gb/responsibility/responsibility-reports/","nodes":[{"title":"Reports archive","url":"/en-gb/responsibility/responsibility-reports/responsibility-reports-archive/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Inclusion","image":{"src":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebc1b88030","alt":"Lab technician smiling","darkModeSrc":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebc1b88030"},"link":{"text":"FEATURED SECTION","href":"/en-gb/responsibility/inclusion/","openInNewWindowText":null}},{"text":"Our policy positions","image":{"src":"/media/110ltmz5/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe9b61b0","alt":"GSK orange texture","darkModeSrc":"/media/110ltmz5/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe9b61b0"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/company/policy-positions/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Investors","url":"/en-gb/investors/","nodes":[{"title":"Why invest in GSK?","url":"/en-gb/investors/why-invest-in-gsk/","nodes":[],"isActive":false},{"title":"Quarterly results","url":"/en-gb/investors/quarterly-results/","nodes":[],"isActive":false},{"title":"Financial reports","url":"/en-gb/investors/financial-reports/","nodes":[{"title":"Annual Report 2025","url":"/en-gb/investors/financial-reports/annual-report-2025/","nodes":[],"isActive":false},{"title":"Corporate reports archive","url":"/en-gb/investors/financial-reports/corporate-reports-archive/","nodes":[],"isActive":false}],"isActive":false},{"title":"Responsible business","url":"/en-gb/investors/responsible-business/","nodes":[],"isActive":false},{"title":"Speeches and presentations","url":"/en-gb/investors/speeches-and-presentations/","nodes":[],"isActive":false},{"title":"Science publications","url":"/en-gb/investors/science-publications/","nodes":[],"isActive":false},{"title":"Events calendar","url":"/en-gb/investors/events-calendar/","nodes":[],"isActive":false},{"title":"Dividend and share price","url":"/en-gb/investors/dividend-and-share-price/","nodes":[{"title":"GSK share price","url":"/en-gb/investors/dividend-and-share-price/gsk-share-price/","nodes":[],"isActive":false},{"title":"Share price calculators (GBp/USD)","url":"/en-gb/investors/dividend-and-share-price/share-price-calculators-gbpusd/","nodes":[],"isActive":false},{"title":"Dividend calculators (GBp/USD)","url":"/en-gb/investors/dividend-and-share-price/dividend-calculators-gbpusd/","nodes":[],"isActive":false},{"title":"Dividend calendar","url":"/en-gb/investors/dividend-and-share-price/dividend-calendar/","nodes":[],"isActive":false}],"isActive":false},{"title":"Analyst consensus","url":"/en-gb/investors/analyst-consensus/","nodes":[],"isActive":false},{"title":"Stock exchange announcements","url":"/en-gb/investors/stock-exchange-announcements/","nodes":[{"title":"London (RNS)","url":"/en-gb/investors/stock-exchange-announcements/london-rns/","nodes":[],"isActive":false},{"title":"London (RNS) inside information","url":"/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","nodes":[],"isActive":false},{"title":"New York (SEC)","url":"/en-gb/investors/stock-exchange-announcements/new-york-sec/","nodes":[],"isActive":false},{"title":"Sign up for announcements","url":"/en-gb/investors/stock-exchange-announcements/sign-up-for-announcements/","nodes":[],"isActive":false}],"isActive":false},{"title":"Shareholder information","url":"/en-gb/investors/shareholder-information/","nodes":[{"title":"Manage your shares","url":"/en-gb/investors/shareholder-information/manage-your-shares/","nodes":[],"isActive":false},{"title":"Annual General Meeting","url":"/en-gb/investors/shareholder-information/annual-general-meeting/","nodes":[],"isActive":false},{"title":"General Meeting","url":"/en-gb/investors/shareholder-information/general-meeting/","nodes":[],"isActive":false},{"title":"Annual Governance Meeting","url":"/en-gb/investors/shareholder-information/annual-governance-meeting/","nodes":[],"isActive":false},{"title":"Corporate sponsored nominee service","url":"/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","nodes":[],"isActive":false},{"title":"Our ADR programme","url":"/en-gb/investors/shareholder-information/adr-programme/","nodes":[],"isActive":false},{"title":"Asset reunification - Georgeson ","url":"/en-gb/investors/shareholder-information/asset-reunification-georgeson/","nodes":[],"isActive":false},{"title":"Share scam alert","url":"/en-gb/investors/shareholder-information/share-scam-alert/","nodes":[],"isActive":false},{"title":"Privacy notice for ordinary shareholders","url":"/en-gb/investors/shareholder-information/privacy-notice-for-ordinary-shareholders/","nodes":[],"isActive":false},{"title":"FAQs","url":"/en-gb/investors/shareholder-information/shareholder-faqs/","nodes":[],"isActive":true}],"isActive":true},{"title":"Corporate actions","url":"/en-gb/investors/corporate-actions/","nodes":[{"title":"Consumer Healthcare Demerger","url":"/en-gb/investors/corporate-actions/consumer-healthcare-demerger/","nodes":[],"isActive":false},{"title":"Consumer Healthcare Joint Venture","url":"/en-gb/investors/corporate-actions/consumer-healthcare-joint-venture/","nodes":[],"isActive":false},{"title":"Agreement to acquire TESARO","url":"/en-gb/investors/corporate-actions/agreement-to-acquire-tesaro/","nodes":[],"isActive":false}],"isActive":false},{"title":"Debt investors","url":"/en-gb/investors/debt-investors/","nodes":[],"isActive":false},{"title":"Investor contacts","url":"/en-gb/investors/investor-contacts/","nodes":[],"isActive":false}],"isActive":true,"promos":[{"text":"Press releases","image":{"src":"/media/hb1dfygw/ware_3_2022_prodassmb_28_hess_nav.jpeg?width=329&height=185&format=webp&quality=100&v=1dba2ebc6f12bb0","alt":"Lab machinery","darkModeSrc":"/media/hb1dfygw/ware_3_2022_prodassmb_28_hess_nav.jpeg?width=329&height=185&format=webp&quality=50&v=1dba2ebc6f12bb0"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/media/press-releases/","openInNewWindowText":null}},{"text":"Our pipeline","image":{"src":"/media/2kyan0vw/ware_3_2022_prodqc_14_hess.jpeg?width=329&height=185&format=webp&quality=100&v=1dba2ebc701f490","alt":"Case of vials","darkModeSrc":"/media/2kyan0vw/ware_3_2022_prodqc_14_hess.jpeg?width=329&height=185&format=webp&quality=50&v=1dba2ebc701f490"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/innovation/pipeline/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-gb/media/","nodes":[{"title":"Press releases","url":"/en-gb/media/press-releases/","nodes":[],"isActive":false},{"title":"Media contacts","url":"/en-gb/media/media-contacts/","nodes":[],"isActive":false},{"title":"Media library","url":"/en-gb/media/media-library/","nodes":[],"isActive":false},{"title":"Zantac litigation","url":"/en-gb/media/zantac-litigation/","nodes":[],"isActive":false},{"title":"GSK's position on Flovent","url":"/en-gb/media/gsks-position-on-flovent/","nodes":[],"isActive":false},{"title":"Our social media","url":"/en-gb/media/social-media/","nodes":[],"isActive":false},{"title":"Podcasts","url":"/en-gb/media/podcasts/","nodes":[],"isActive":false},{"title":"RSS feeds","url":"/en-gb/media/rss-feeds/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Behind the science magazine","image":{"src":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebb585f130","alt":"Scientist works in a futurist vaccine laboratory for GSK","darkModeSrc":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebb585f130"},"link":{"text":"Spotlight on","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-gb/careers/","nodes":[{"title":"Search jobs","url":"/en-gb/careers/search-jobs/","nodes":[],"isActive":false},{"title":"Featured careers","url":"/en-gb/careers/featured-careers/","nodes":[{"title":"A career in data","url":"/en-gb/careers/featured-careers/a-career-in-data/","nodes":[],"isActive":false}],"isActive":false},{"title":"Life at GSK","url":"/en-gb/careers/life-at-gsk/","nodes":[],"isActive":false},{"title":"Outstanding people","url":"/en-gb/careers/outstanding-people/","nodes":[{"title":"Great place to work","url":"/en-gb/careers/outstanding-people/great-place-to-work/","nodes":[],"isActive":false},{"title":"Meet our veterans","url":"/en-gb/careers/outstanding-people/meet-our-veterans/","nodes":[],"isActive":false},{"title":"Working together","url":"/en-gb/careers/outstanding-people/working-together/","nodes":[],"isActive":false},{"title":"My GSK story","url":"/en-gb/careers/outstanding-people/my-gsk-story/","nodes":[],"isActive":false},{"title":"Innovating together","url":"/en-gb/careers/outstanding-people/innovating-together/","nodes":[],"isActive":false}],"isActive":false},{"title":"Experienced professionals","url":"/en-gb/careers/experienced-professionals/","nodes":[{"title":"Business operations","url":"/en-gb/careers/experienced-professionals/business-operations/","nodes":[],"isActive":false},{"title":"Engineering at GSK ","url":"/en-gb/careers/experienced-professionals/engineering/","nodes":[],"isActive":false},{"title":"Global supply chain","url":"/en-gb/careers/experienced-professionals/global-supply-chain/","nodes":[],"isActive":false},{"title":"Sales and marketing","url":"/en-gb/careers/experienced-professionals/sales-and-marketing/","nodes":[],"isActive":false},{"title":"Research and development","url":"/en-gb/careers/experienced-professionals/research-and-development/","nodes":[{"title":"Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)","url":"/en-gb/careers/experienced-professionals/research-and-development/chemical-manufacturing-and-controls-cmc-medicine-development-and-supply-mds/","nodes":[],"isActive":false},{"title":"Genomic sciences","url":"/en-gb/careers/experienced-professionals/research-and-development/genomic-sciences/","nodes":[],"isActive":false}],"isActive":false},{"title":"Technology","url":"/en-gb/careers/experienced-professionals/technology/","nodes":[],"isActive":false}],"isActive":false},{"title":"Early careers","url":"/en-gb/careers/early-careers/","nodes":[{"title":"Application process","url":"/en-gb/careers/early-careers/application-process/","nodes":[],"isActive":false},{"title":"Apprentice programmes","url":"/en-gb/careers/early-careers/apprentice-programmes/","nodes":[],"isActive":false},{"title":"Internships and placements","url":"/en-gb/careers/early-careers/internships-and-placements/","nodes":[],"isActive":false},{"title":"Graduate programme","url":"/en-gb/careers/early-careers/graduate-programme/","nodes":[{"title":"Business operations","url":"/en-gb/careers/early-careers/graduate-programme/business-operations/","nodes":[],"isActive":false},{"title":"Engineering","url":"/en-gb/careers/early-careers/graduate-programme/engineering/","nodes":[],"isActive":false},{"title":"Manufacturing & supply","url":"/en-gb/careers/early-careers/graduate-programme/manufacturing-supply/","nodes":[],"isActive":false},{"title":"Commercial ","url":"/en-gb/careers/early-careers/graduate-programme/commercial/","nodes":[],"isActive":false},{"title":"Research & development","url":"/en-gb/careers/early-careers/graduate-programme/research-development/","nodes":[],"isActive":false},{"title":"Digital & tech","url":"/en-gb/careers/early-careers/graduate-programme/digital-tech/","nodes":[],"isActive":false},{"title":"Manufacturing sciences & technology","url":"/en-gb/careers/early-careers/graduate-programme/manufacturing-sciences-technology/","nodes":[],"isActive":false}],"isActive":false},{"title":"Post graduate opportunities","url":"/en-gb/careers/early-careers/post-graduate-opportunities/","nodes":[],"isActive":false},{"title":"Frequently asked questions","url":"/en-gb/careers/early-careers/frequently-asked-questions/","nodes":[],"isActive":false}],"isActive":false},{"title":"Veterans","url":"/en-gb/careers/veterans/","nodes":[],"isActive":false},{"title":"Our global and regional hubs","url":"/en-gb/careers/our-global-and-regional-hubs/","nodes":[],"isActive":false},{"title":"How we hire","url":"/en-gb/careers/how-we-hire/","nodes":[{"title":"Fraudulent internet recruitment activities","url":"/en-gb/careers/how-we-hire/fraudulent-internet-recruitment-activities/","nodes":[],"isActive":false},{"title":"Frequently asked questions","url":"/en-gb/careers/how-we-hire/frequently-asked-questions/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Outstanding people","image":{"src":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=100&v=1dba2eba773f3d0","alt":"Angeles sitting on a sofa in a pink shirt","darkModeSrc":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=50&v=1dba2eba773f3d0"},"link":{"text":"Spotlight on","href":"/en-gb/careers/outstanding-people/","openInNewWindowText":null}},{"text":"Inclusion","image":{"src":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebc1b88030","alt":"Lab technician smiling","darkModeSrc":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebc1b88030"},"link":{"text":"Spotlight on","href":"/en-gb/responsibility/inclusion/","openInNewWindowText":null}}]}],"skipToContent":"Skip to content","skipToSearch":"Skip to search","typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1703","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-gb/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"

This is our global website, intended for visitors seeking information on GSK's worldwide business.  Our market sites can be reached by visiting our location selector.  

\n

 

\n

© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

\n

GSK plc. Registered in England and Wales No. 3888792.

\n

Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG

","modernSlaveryStatement":{"name":"Modern Slavery Act Statement 2025","url":"/media/5ladhmeu/modern-slavery-act-statement-2025.pdf","fileExtension":"PDF","fileSize":"187.7KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window"},"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"http://www.linkedin.com/company/glaxosmithkline","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK on Linkedin","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"http://twitter.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK X page","customIcon":null,"showPopupMenu":false,"type":"X"},{"globalLink":{"text":null,"href":"https://bsky.app/profile/gsk.bsky.social/","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"","customIcon":null,"showPopupMenu":false,"type":"Bluesky"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gsk/","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"},{"globalLink":{"text":null,"href":"https://www.facebook.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK Facebook page","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"http://www.youtube.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK YouTube Channel","customIcon":null,"showPopupMenu":false,"type":"Youtube"},{"globalLink":{"text":null,"href":"/en-gb/media/rss-feeds/","openInNewWindowText":null},"localLink":null,"ariaLabel":"Visit GSK RSS feeds","customIcon":null,"showPopupMenu":false,"type":"Rss"}]},"columns":[{"columnTitle":"GSK websites","links":[{"text":"Locations selector","href":"/en-gb/locations/","openInNewWindowText":null},{"text":"Social media directory","href":"/en-gb/media/social-media/","openInNewWindowText":null},{"text":"GSKPro for healthcare professionals","href":"https://www.gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK study register","href":"https://www.gsk-studyregister.com/en/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Supplier website","href":"https://supplier.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Behind the Science magazine","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null},{"text":"Company","href":"/en-gb/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-gb/innovation/","openInNewWindowText":null},{"text":"Products","href":"/en-gb/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-gb/responsibility/","openInNewWindowText":null},{"text":"Investors","href":"/en-gb/investors/","openInNewWindowText":null},{"text":"Media","href":"/en-gb/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-gb/careers/","openInNewWindowText":null}]},{"columnTitle":"Get in touch","links":[{"text":"Contact us","href":"/en-gb/contact-us/","openInNewWindowText":null},{"text":"Partnerships","href":"/en-gb/innovation/partnerships/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-gb/contact-us/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK Speak up","href":"https://www.gsk.com/speakup","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-gb/accessibility/","openInNewWindowText":null},{"text":"Digital sustainability","href":"/en-gb/digital-sustainability/","openInNewWindowText":null},{"text":"Terms of use","href":"/en-gb/terms-of-use/","openInNewWindowText":null},{"text":"Cookie policy","href":"/en-gb/cookie-policy/","openInNewWindowText":null},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-gb/privacy-notice/general","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-gb/sitemap/","openInNewWindowText":null}],"continueToLink":{"text":"Corporate actions","href":"/en-gb/investors/corporate-actions/","openInNewWindowText":null,"continueTo":""},"legalApprovalText":""},"sharing":{"description":"This page is dedicated to answering frequently asked GSK shareholder questions","og":[{"property":"og:title","content":"FAQs"},{"property":"og:description","content":"This page is dedicated to answering frequently asked GSK shareholder questions"},{"property":"og:image","content":"https://www.gsk.com/media/wtsnej4d/gsk_texture_fluid_04_a_cmyk-web-size.jpg?width=600&format=webp&quality=100&v=1dba2ec225d8f20"},{"property":"og:url","content":"https://www.gsk.com/en-gb/investors/shareholder-information/shareholder-faqs/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"FAQs"},{"name":"twitter:description","content":"This page is dedicated to answering frequently asked GSK shareholder questions"},{"name":"twitter:image","content":"https://www.gsk.com/media/wtsnej4d/gsk_texture_fluid_04_a_cmyk-web-size.jpg?width=600&format=webp&quality=100&v=1dba2ec225d8f20"},{"name":"twitter:url","content":"https://www.gsk.com/en-gb/investors/shareholder-information/shareholder-faqs"}]},"stickyShare":null,"exitSitePreferences":{"popupEnabled":false,"title":"","texts":"","continueText":"Continue","cancelText":"Cancel","exclusionUrls":[]},"settings":{"optionalStylesheetLink":null,"themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://www.gsk.com/media/0jwou3xu/gsk-logo.png?width=104&format=webp&quality=100&v=1dbf4b05a4e6470","alt":"Gsk Logo","darkModeSrc":"https://www.gsk.com/media/0jwou3xu/gsk-logo.png?width=104&format=webp&quality=50&v=1dbf4b05a4e6470"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":null,"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"70ab0a79-1d92-4286-86d2-abdd71cc785c","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://www.gsk.com/en-gb/investors/shareholder-information/shareholder-faqs/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":{"jsonLdSchemas":["{\"@context\":\"https://schema.org\",\"@type\":\"FAQPage\",\"name\":\"FAQs\",\"description\":\"This page is dedicated to answering frequently asked GSK shareholder questions\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Who are your Registrars/Depositary Bank and how/why should I contact them?\",\"about\":{\"@type\":\"Thing\",\"name\":\"General FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Our registrars for ordinary shareholders are Computershare Investor Services PLC (Computershare), and our depositary bank for ADR holders is JPMorgan Chase Bank (JPM). They look after our register and are responsible for ensuring that shareholder details are recorded accurately. You should contact our registrars or depositary for anything related to your shareholding, for example:\\u2022 To inform of a change of name, address, or bank details.\\u2022 To request a reissue of a dividend cheque.\\u2022 To change how your dividends are paid.\\u2022 To inform of a lost share certificate in case of shareholder death.Both Computershare and JPM can be contacted by phone or post, and their contact details can be found on the Investors contact details page. Most of these changes can also be made online, by registering for an Investor Centre account if you are an ordinary shareholder or for an EQ shareowner account if you hold ADRs.\\u0026nbsp;\"}},{\"@type\":\"Question\",\"name\":\"Where can I find information about share prices?\",\"about\":{\"@type\":\"Thing\",\"name\":\"General FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The current share price can also be found on the home page of our website. You can also access this information on the Investors section of the GSK website under GSK Share price, and Share price calculators, which include more detailed analysis and historical share prices.\"}},{\"@type\":\"Question\",\"name\":\"When did the change of registrar happen and what does it mean to me?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The change of registrar occurred on 28 October 2024. You will receive a Welcome Letter or email, depending on your communication preferences, from Computershare after the change occurs and will be issued with a new Shareholder Reference Number. Please see information below on how to register an online account with Computershare via www.investorcentre.co.uk to manage your shareholding. Computershare can assist with queries with effect from 28 October 2024.\"}},{\"@type\":\"Question\",\"name\":\"Have my previous instructions for payment of dividends been carried over from EQ?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"For the vast majority of holders, payment instructions have been carried over. There are some holdings for which details have not been transferred over. In this instance, Computershare will confirm this information in the Welcome Letter and will provide instructions on how to update your details.\"}},{\"@type\":\"Question\",\"name\":\"Is my EQ share certificate still valid?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, any certificate(s) issued by EQ will remain valid.\"}},{\"@type\":\"Question\",\"name\":\"Does the previously registered Power of Attorney (POA), or probate and executor details get carried over?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, any details registered with EQ will be carried over to Computershare. Please note that if the value of the holding exceeds \\u00A325,000, we will need to request submission of documentation to Computershare before any material changes are made to the holding.\"}},{\"@type\":\"Question\",\"name\":\"Have my previous instructions for receipt of communications been carried over from EQ? Can I amend my communication method from postal to email and how?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, your instruction has been carried over, but if you wish, you can register an account via www.investorcentre.co.uk and amend your communication preference.\"}},{\"@type\":\"Question\",\"name\":\"How do I view or amend my details online?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Please visit www.investorcentre.co.uk and register an account to view your holding. You can add/amend your payment details, elect for the DRIP, sell your shares, update your address and a number of other items.\"}},{\"@type\":\"Question\",\"name\":\"Does Computershare offer a dealing facility?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, you can buy and sell your GSK shares by logging into your Investor Centre account. Please visit www.computershare.com/dealing/uk for more information.\"}},{\"@type\":\"Question\",\"name\":\"What are Computershare\\u2019s contact details?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Please see below:Computershare Investor Services PLCThe Pavilions, Bridgwater RoadBristol, BS99 6ZZTel: \\u002B44 (0)370 707 1595Help | Investor Centre (computershare.com)Computershare\\u2019s contact details can also be found on the Investors contact details page.\"}},{\"@type\":\"Question\",\"name\":\"How can I arrange for any outstanding dividends to be paid to my bank account?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Please contact Computershare using the contact details on the Investors contact details page. Computershare will arrange for any outstanding payments to be issued direct to your bank details. Please note: if you update / add your bank details with Computershare, any outstanding dividend payments will automatically be issued to your bank account.\"}},{\"@type\":\"Question\",\"name\":\"How do I obtain my Shareholder Reference Number?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Registrar switch from Equiniti (EQ) to Computershare FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Your Shareholder Reference Number will be detailed on your Welcome Letter or email, depending on the communication preference registered under EQ, which will be issued in due course.\"}},{\"@type\":\"Question\",\"name\":\"How can I manage my shareholding online? \",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can create a Computershare Investor Centre account to manage your shareholding online. This will enable you to check the balance of your holding, update your records if you change your address or bank account details, and set up paper-free share communications. More details can be found using the following link Investor Centre (computershare.com).\"}},{\"@type\":\"Question\",\"name\":\"How can I buy or sell GSK shares?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Shares cannot be bought directly through GSK but can be purchased through your bank or stockbroker. Computershare, our registrar, also offer a share dealing service which allows you to trade online or by post \\u2013 it is a relatively fast and secure way to deal. Further information can be found on Computershare\\u2019s website www.computershare.com/dealing/uk.\"}},{\"@type\":\"Question\",\"name\":\"How do I transfer my certificated shares to another person/a joint account?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You will need to complete a Stock Transfer Form and return it to Computershare with your valid share certificate(s). You can get a copy of a Stock Transfer Form by downloading it from Computershare\\u2019s Investor Centre website or by contacting the customer service team.\"}},{\"@type\":\"Question\",\"name\":\"How do I transfer shares after a shareholder death?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You will need to contact Computershare, who will place a temporary restriction on the register. You will then need to formally register the shareholder\\u2019s death by providing a certified copy of the Grant of Probate or using Computershare\\u2019s Small Estates Service to sell or transfer shares. More information regarding this process can be found using the Deceased Estate Sales Service Share Dealing Investor Centre (computershare.com).\"}},{\"@type\":\"Question\",\"name\":\"How do I transfer my shares held in the GSK Corporate Sponsored Nominee?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can deposit and withdraw your shares (to certificate and to broker). You will need to complete a form that you can download from Investor Centre Printable Forms by typing in GSK in the company name and looking under Company Nominee Service.\"}},{\"@type\":\"Question\",\"name\":\"Is UK stamp duty payable on the share transfer?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This depends on the nature of the transfer. A guidance note concerning the application of stamp duty on the share transfer form is set out under section 9 of \\u2018How to complete this form\\u0027. Please contact your accountant, financial adviser or lawyer if you have further questions in this regard.\"}},{\"@type\":\"Question\",\"name\":\"How do I arrange for dividends to be paid directly to my account?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This can be done online with a Computershare Investor Centre account or over the phone. You will need to quote your Shareholder Reference Number (SRN), a letter followed by a 10-digit number which can be found on your share certificate or on any previous correspondence we have sent you.\"}},{\"@type\":\"Question\",\"name\":\"How do I notify of a change of address and/or bank details?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can register with an Investor Centre account to make these changes online. If you don\\u2019t have an Investor Centre account, you can register directly online or you will need to contact Computershare directly by phone or post using the details found above.\"}},{\"@type\":\"Question\",\"name\":\"How do I notify a change of name?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"To update your name, an instruction should be sent in writing to Computershare at the address above or by using a change of name form which can be found in the downloadable forms section for GSK at Investor Centre Printable Forms (computershare.com). All applications to change a registered name need to be accompanied by supporting documentation. For proof of marriage, we require either the original or an official copy of the Marriage Certificate. For all other documents, we require either the original or a certified copy.\"}},{\"@type\":\"Question\",\"name\":\"I have lost my share certificate. What should I do?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You will need to contact Computershare, who will place a restriction on the lost certificate to prevent fraudulent use. A new certificate can be issued, which is done by completing and returning a Letter of Indemnity. There is a cost to Computershare in issuing a replacement certificate, and so there may be a fee charged for this process. You will need to wait for a replacement certificate in order to transfer or sell your shares.\"}},{\"@type\":\"Question\",\"name\":\"How do I obtain a copy of a share certificate and other shareholder documents?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It is not possible to issue a copy of a share certificate. If you have lost your share certificate, please contact Computershare who will follow the process for a lost certificate (shown above). Other shareholder documents can be obtained by logging into your Investor Centre account or contacting Computershare.\"}},{\"@type\":\"Question\",\"name\":\"How can I find out the balance of my shareholdings?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Shareholding balance can be found by contacting Computershare via the details on the Investors contact details page. Alternatively, registering an Investor Centre account enables you to access the balance of your holdings online by logging onto your account \\u2013 details on setting up a portfolio can be found above.\"}},{\"@type\":\"Question\",\"name\":\"How can I avoid receiving multiple copies of shareholder circulars?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This is likely to have occurred because Computershare is holding two (or more) accounts for you on the share register. If you would like to merge shareholdings registered in your name into a single holding, please provide Computershare with a written request, signed by all the registered holders or legally appointed representatives.You may have a preference as to which holding you would like the shares to be merged. If so, please inform Computershare by confirming the Shareholder Reference Number (SRN). This is an 11-digit number which can be found on your share certificate or on any previous correspondence we have sent you. There is no need to send Computershare your share certificates, as these will remain valid.\"}},{\"@type\":\"Question\",\"name\":\"How can I consolidate my share certificates?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Ordinary shareholders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If your certificated holding in GSK is represented by several share certificates you may wish to have these replaced by one consolidated share certificate. You should send your certificates (preferably by courier or recorded delivery to minimise them getting lost in the post) with a letter of instruction to Computershare.\"}},{\"@type\":\"Question\",\"name\":\"How can I buy or sell GSK ADRs?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GSK\\u2019s depositary bank, JPMorgan Chase Bank N.A. (\\u201CJPMorgan\\u201D), operates a Global Invest Direct programme which allows first time and existing investors to purchase and/or sell ADRs. For further details and to obtain an enrolment pack, please visit www.shareowneronline.com.Alternatively, please contact your bank or stock broker who should be able to advise you on how to buy GSK ADRs.\"}},{\"@type\":\"Question\",\"name\":\"What is the difference between ADRs and ADSs?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"An American Depository Receipt (ADR) is issued by a depository bank (JPMorgan in GSK\\u2019s case), and is used to represent a specific number of shares of a non-US company traded on a US stock exchange. This allows non-US companies to make their shares available outside their home markets and allows investors in the US and elsewhere to easily invest in companies.American Depository Shares (ADS) are the actual shares which are traded and, in the case of GSK, listed on the New York Stock Exchange. The terms ADR and ADS are often used interchangeably.One GSK ADR represents two Ordinary Shares held by JPMorgan.\"}},{\"@type\":\"Question\",\"name\":\"How do GSK\\u2019s ADRs trade?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GSK ADRs are issued by the depositary bank, JPMorgan. The underlying ordinary shares are deposited by a local custodian bank, usually by a broker who has purchased the ordinary shares in the open market. Once issued, GSK ADRs may be traded in the US on the New York Stock Exchange.When the ADR holder sells, the ADR can either be sold to another investor in the US market or cancelled. In the latter case, the ADR is surrendered to the depositary, and the ordinary shares held with the depositary\\u2019s custodian would be released back into the home market (i.e. the UK). A GSK ADR holder is able to request delivery of the underlying GSK Ordinary Shares at any time.\"}},{\"@type\":\"Question\",\"name\":\"Who should I contact with queries regarding ADRs?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The depositary we use is JPMorgan Chase Bank N.A., whose contact details can be found above.\"}},{\"@type\":\"Question\",\"name\":\"Can I vote at the AGM if I hold ADRs?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Holders of GSK ADRs are entitled to instruct JPMorgan as to how to vote in relation to their shareholding at the respective Annual General Meetings or General Meetings. The voting rights are in relation to the number of GSK Ordinary Shares represented by the respective ADRs. If you choose not to instruct JPM, your shares will not be voted.\"}},{\"@type\":\"Question\",\"name\":\"How do I obtain a copy of shareholder documents?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Paper copies of shareholder documents, such as Annual Reports, can be obtained by contacting JPMorgan, directly. Their contact details can be found above. GSK also makes soft copies of most documents, which can be found under \\u2018Investors \\u2013 Corporate Reporting\\u2019 on our website.\\u0026nbsp;\"}},{\"@type\":\"Question\",\"name\":\"How are the dividend payments on ADRs calculated, and what currency are they paid in?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ADR dividends are paid in US dollars. The dividend amount paid on ADRs is calculated by converting the dividend amount in pounds sterling to US dollars, using the exchange rate as at close of business two days prior to the payment date. Please note that the US dividend is also subject to a dividend fee of $0.0075 per ADR.\\u0026nbsp;(The US dollar dividend amount received is likely to differ from the US dollar determining rate announced in the quarterly results due to the currency fluctuations between the date the dividend is declared and two days before the payment date).\"}},{\"@type\":\"Question\",\"name\":\"Why does GSK not pay dividends on ADRs in the US dollar determining rate?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The ADR depositary is entitled to receive dividends in pounds sterling, which is the currency in which GSK\\u0027s dividends are declared. Payment in the US dollar determining rate would expose GSK to foreign currency fluctuations arising from movements between ADRs and share registers.\"}},{\"@type\":\"Question\",\"name\":\"Is there a dividend reinvestment plan for ADR holders?\",\"about\":{\"@type\":\"Thing\",\"name\":\"ADR Holders FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"JPMorgan provides a Global Invest Direct programme, a direct ADS dividend reinvestment plan for ADR holders. For details on how to enrol please visit www.shareowneronline.com\\u0026nbsp; or call the above helpline number to obtain an enrolment pack.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find information about GSK\\u2019s dividend policy?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Dividend FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The company pays dividends quarterly to shareholders who are named on the register on the \\u201Crecord date\\u201D. The dividend rate is announced with the quarterly financial results announcements and is determined in pounds sterling.Historical dividend information can be found on the GSK website under Dividend calculators.\\u0026nbsp;\"}},{\"@type\":\"Question\",\"name\":\"What is the \\u201Cex-dividend\\u201D date?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Dividend FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The ex-dividend date marks the first day when buyers of shares are not entitled to the previously announced dividend. Before this date, shares are said to be \\u2018cum-dividend\\u2019: if you buy shares during this period, you are entitled to the dividend which has just been announced. However, if you purchase shares on or after the ex-dividend date you are\\u0026nbsp;not\\u0026nbsp;entitled to the pending dividend \\u2013 the previous owner of the shares is.\"}},{\"@type\":\"Question\",\"name\":\"What is the \\u201Crecord date\\u201D?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Dividend FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The record date is exactly one business day after the ex-dividend date. On this date, the registrar will view the share register and determine who will receive dividends by confirming who is recorded on the register on this date. If you buy shares on the ex-dividend date, you will not appear on the register until after the record date, so will not receive the most recent dividend payment.\"}},{\"@type\":\"Question\",\"name\":\"How do I calculate dividend payments?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Dividend FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A dividend calculator can be found on the GSK website Dividend calculators.To calculate, enter the number of Ordinary shares or ADRs owned when dividend was paid. This page also provides quarterly dividend rates since 2001.\\u0026nbsp;\"}},{\"@type\":\"Question\",\"name\":\"How does the Dividend Reinvestment Plan (DRIP) work?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Dividend FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The GSK Dividend Reinvestment Plan (DRIP) is a service offered by Computershare in which you can use your cash dividends to buy more shares in GSK. As an alternative to the dividend payment, your cash will be used to buy additional shares. The DRIP is a convenient, easy and cost-effective way to build your shareholding.Please note that a commission charge of 1 per cent of the value of the shares purchased will be charged by Computershare, and purchases will also be liable to stamp duty at a rate of 0.5 per cent of the value of the shares purchased.To apply for the GSK DRIP, call \\u002B44 (0)370 707 1595, download a DRIP form from the printable forms section for GSK at Investor Centre Printable Forms (computershare.com), or in your Investor Centre account.\"}},{\"@type\":\"Question\",\"name\":\"Can I elect to receive my dividends abroad in currencies other than pounds sterling?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Dividend FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Computershare have an International Funds service in place, through which they can send dividends to overseas bank accounts. If you need to update or add a payment instruction to your shareholding, the most secure approach is to register with the Investor Centre.\"}},{\"@type\":\"Question\",\"name\":\"What do I do if I find an out-of-date cheque?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Dividend FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If you find a dividend cheque which is now out-of-date, you can contact Computershare to arrange for your uncashed dividends to be paid directly into a nominated bank or building society account.\"}},{\"@type\":\"Question\",\"name\":\"Why did GSK make this change?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Receiving dividends by direct credit rather than cheque is a more efficient, secure and environmentally friendly method of payment. It is also cost effective for shareholders as failure to cash cheques before the expiration date may incur cheque reissue fees.\"}},{\"@type\":\"Question\",\"name\":\"When did GSK stop sending cheques?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"January 2020 was the last dividend payment for which you were able to receive a cheque. From April 2020 any monies payable in connection with your shares will only be paid by direct credit.\"}},{\"@type\":\"Question\",\"name\":\"What if I didn\\u0027t provide my bank or building society account details?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If you do not provide this information, you will still receive an annual dividend statement; however, you will not receive the money until your bank details are received, after which payment will be credited to your account as soon as possible. Your dividends will not accrue interest while they are being held for you and there will be a fee for Computershare to reissue payments.\"}},{\"@type\":\"Question\",\"name\":\"What is direct credit?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Direct credit is a commonly used means of payment whereby funds are transferred directly into the recipient\\u2019s bank account, rather than by providing a cheque that must subsequently be cashed. Direct credit is a more secure method of payment than cheques. It is used by most large organisations to pay, for example, employees\\u2019 salaries.\"}},{\"@type\":\"Question\",\"name\":\"How much does direct credit cost?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"There is no fee charged by GSK or Computershare for this service.\"}},{\"@type\":\"Question\",\"name\":\"What type of account can I nominate?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can nominate any UK bank or building society account in your name.\"}},{\"@type\":\"Question\",\"name\":\"What if I want to change my nominated account?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"By registering for an Investor Centre holding, you can manage many aspects of your shareholding online, including updating your bank details. If you are a sole shareholder, you can also update your bank details by calling Computershare, our registrar.\"}},{\"@type\":\"Question\",\"name\":\"When will I receive my dividend payment?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dividends will be paid into your nominated bank or building society account as cleared funds on the dividend payment date.\"}},{\"@type\":\"Question\",\"name\":\"How will I know that my dividend has been paid?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If you register for electronic communications using the Computershare Investor Centre - UK, you will be sent an electronic notification on the day the dividend is paid. If you are not registered, you will receive an annual consolidated dividend statement by post setting out details of all dividends paid to you in the previous twelve months. These statements are currently sent out in January each year.\"}},{\"@type\":\"Question\",\"name\":\"Can I receive a dividend statement on the day the dividend is paid?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If you do not want to register for electronic communications or receive an annual consolidated dividend statement by post in January each year, then please contact Computershare to request individual dividend statements. These statements will be posted out by second class two days before each dividend payment date so that you receive it on the day the dividend is paid into your bank/building society account.\"}},{\"@type\":\"Question\",\"name\":\"How do I provide the registrar with my UK bank or building society account details?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"To set up direct dividend payments, log in to your Investor Centre account and enter your bank details. Please visit the Investor Centre for details on how to register.Alternatively, you can contact Computershare directly. Their contact details can be found on the Investors contact details page.\"}},{\"@type\":\"Question\",\"name\":\"Can I reinvest my dividends instead?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Instead of receiving dividend payments into your bank or building society account, you may wish to build up your shareholding in GSK by using your dividends to purchase further GSK shares. The GSK Dividend Reinvestment Programme (\\u2018DRIP\\u2019) is a convenient, easy and cost-effective way to do this. Visit Dividend Reinvestment Plan for more information and a DRIP application form.Please note: If you are not eligible to join the DRIP, or you revoke your DRIP instruction, you will need to provide your bank or building society account details in order for future dividends to be paid to you.\"}},{\"@type\":\"Question\",\"name\":\"What is the Computershare International Funds Transfer Service?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If you do not have a UK bank or building society account, you may be able to arrange for payments to be converted and paid in your local currency using the Computershare International Funds Transfer. This service pays in 11 currencies to over 200 different countries. To register for fast and secure payments internationally please visit the Investor Centre.\"}},{\"@type\":\"Question\",\"name\":\"What gives GSK the authority to remove dividend cheques?\",\"about\":{\"@type\":\"Thing\",\"name\":\"Mandated Direct Credit FAQs\"},\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The decision to pay dividends by direct credit, rather than cheque, has been taken to increase the security of payments, decrease costs and reduce our impact on the environment. Under the company\\u2019s articles of association, which were approved by shareholders at the 2018 Annual General Meeting, the directors have authority to determine the method by which the company\\u2019s dividends are paid, including by direct credit.Annual General Meeting Archive\"}}]}"]},"modules":[{"type":"page-nav","ariaLabel":"Secondary","menuItems":[{"title":"General FAQs","anchorName":"GeneralFAQs"},{"title":"Change of Registrar","anchorName":"ChangeofRegistrar"},{"title":"Ordinary shareholders","anchorName":"Ordinaryshareholders"},{"title":"ADR Holders","anchorName":"ADRHolders"},{"title":"Dividend","anchorName":"Dividend"},{"title":"Mandated Direct Credit","anchorName":"MandatedDirectCredit"}],"ariaLabelNextSlide":"Next slide","ariaLabelPreviousSlide":"Previous slide"},{"type":"anchor","menuTitle":"General FAQs","anchorName":"GeneralFAQs","nestedModule":{"type":"faqs","sectionHeading":"General FAQs","collapseAllText":"Close all","expandAllText":"Expand all","questions":[{"question":"Who are your Registrars/Depositary Bank and how/why should I contact them?","answer":"

Our registrars for ordinary shareholders are Computershare Investor Services PLC (Computershare), and our depositary bank for ADR holders is JPMorgan Chase Bank (JPM). They look after our register and are responsible for ensuring that shareholder details are recorded accurately. You should contact our registrars or depositary for anything related to your shareholding, for example:

\n

• To inform of a change of name, address, or bank details.

\n

• To request a reissue of a dividend cheque.

\n

• To change how your dividends are paid.

\n

• To inform of a lost share certificate in case of shareholder death.

\n

Both Computershare and JPM can be contacted by phone or post, and their contact details can be found on the Investors contact details page. Most of these changes can also be made online, by registering for an Investor Centre account if you are an ordinary shareholder or for an EQ shareowner account if you hold ADRs.

\n

 

"},{"question":"Where can I find information about share prices?","answer":"

The current share price can also be found on the home page of our website. You can also access this information on the Investors section of the GSK website under GSK Share price, and Share price calculators, which include more detailed analysis and historical share prices.

"}]}},{"type":"anchor","menuTitle":"Change of Registrar","anchorName":"ChangeofRegistrar","nestedModule":{"type":"spacer","label":""}},{"type":"faqs","sectionHeading":"Registrar switch from Equiniti (EQ) to Computershare FAQs","collapseAllText":"Close all","expandAllText":"Expand all","questions":[{"question":"When did the change of registrar happen and what does it mean to me?","answer":"

The change of registrar occurred on 28 October 2024. You will receive a Welcome Letter or email, depending on your communication preferences, from Computershare after the change occurs and will be issued with a new Shareholder Reference Number. Please see information below on how to register an online account with Computershare via www.investorcentre.co.uk to manage your shareholding. Computershare can assist with queries with effect from 28 October 2024.

"},{"question":"Have my previous instructions for payment of dividends been carried over from EQ?","answer":"

For the vast majority of holders, payment instructions have been carried over. There are some holdings for which details have not been transferred over. In this instance, Computershare will confirm this information in the Welcome Letter and will provide instructions on how to update your details.

"},{"question":"Is my EQ share certificate still valid?","answer":"

Yes, any certificate(s) issued by EQ will remain valid.

"},{"question":"Does the previously registered Power of Attorney (POA), or probate and executor details get carried over?","answer":"

Yes, any details registered with EQ will be carried over to Computershare. Please note that if the value of the holding exceeds £25,000, we will need to request submission of documentation to Computershare before any material changes are made to the holding.

"},{"question":"Have my previous instructions for receipt of communications been carried over from EQ? Can I amend my communication method from postal to email and how?","answer":"

Yes, your instruction has been carried over, but if you wish, you can register an account via www.investorcentre.co.uk and amend your communication preference.

"},{"question":"How do I view or amend my details online?","answer":"

Please visit www.investorcentre.co.uk and register an account to view your holding. You can add/amend your payment details, elect for the DRIP, sell your shares, update your address and a number of other items.

"},{"question":"Does Computershare offer a dealing facility?","answer":"

Yes, you can buy and sell your GSK shares by logging into your Investor Centre account. Please visit www.computershare.com/dealing/uk for more information.

"},{"question":"What are Computershare’s contact details?","answer":"

Please see below:

\n

Computershare Investor Services PLC
The Pavilions, Bridgwater Road
Bristol, BS99 6ZZ

\n

Tel: +44 (0)370 707 1595

\n

Help | Investor Centre (computershare.com)

\n

Computershare’s contact details can also be found on the Investors contact details page.

"},{"question":"How can I arrange for any outstanding dividends to be paid to my bank account?","answer":"

Please contact Computershare using the contact details on the Investors contact details page. Computershare will arrange for any outstanding payments to be issued direct to your bank details. Please note: if you update / add your bank details with Computershare, any outstanding dividend payments will automatically be issued to your bank account.

"},{"question":"How do I obtain my Shareholder Reference Number?","answer":"

Your Shareholder Reference Number will be detailed on your Welcome Letter or email, depending on the communication preference registered under EQ, which will be issued in due course.

"}]},{"type":"anchor","menuTitle":"Ordinary shareholders","anchorName":"Ordinaryshareholders","nestedModule":{"type":"spacer","label":""}},{"type":"faqs","sectionHeading":"Ordinary shareholders FAQs","collapseAllText":"Close all","expandAllText":"Expand all","questions":[{"question":"How can I manage my shareholding online? ","answer":"

You can create a Computershare Investor Centre account to manage your shareholding online. This will enable you to check the balance of your holding, update your records if you change your address or bank account details, and set up paper-free share communications. More details can be found using the following link Investor Centre (computershare.com).

"},{"question":"How can I buy or sell GSK shares?","answer":"

Shares cannot be bought directly through GSK but can be purchased through your bank or stockbroker. Computershare, our registrar, also offer a share dealing service which allows you to trade online or by post – it is a relatively fast and secure way to deal. Further information can be found on Computershare’s website www.computershare.com/dealing/uk.

"},{"question":"How do I transfer my certificated shares to another person/a joint account?","answer":"

You will need to complete a Stock Transfer Form and return it to Computershare with your valid share certificate(s). You can get a copy of a Stock Transfer Form by downloading it from Computershare’s Investor Centre website or by contacting the customer service team.

"},{"question":"How do I transfer shares after a shareholder death?","answer":"

You will need to contact Computershare, who will place a temporary restriction on the register. You will then need to formally register the shareholder’s death by providing a certified copy of the Grant of Probate or using Computershare’s Small Estates Service to sell or transfer shares. More information regarding this process can be found using the Deceased Estate Sales Service Share Dealing Investor Centre (computershare.com).

"},{"question":"How do I transfer my shares held in the GSK Corporate Sponsored Nominee?","answer":"

You can deposit and withdraw your shares (to certificate and to broker). You will need to complete a form that you can download from Investor Centre Printable Forms by typing in GSK in the company name and looking under Company Nominee Service.

"},{"question":"Is UK stamp duty payable on the share transfer?","answer":"

This depends on the nature of the transfer. A guidance note concerning the application of stamp duty on the share transfer form is set out under section 9 of ‘How to complete this form'. Please contact your accountant, financial adviser or lawyer if you have further questions in this regard.

"},{"question":"How do I arrange for dividends to be paid directly to my account?","answer":"

This can be done online with a Computershare Investor Centre account or over the phone. You will need to quote your Shareholder Reference Number (SRN), a letter followed by a 10-digit number which can be found on your share certificate or on any previous correspondence we have sent you.

"},{"question":"How do I notify of a change of address and/or bank details?","answer":"

You can register with an Investor Centre account to make these changes online. If you don’t have an Investor Centre account, you can register directly online or you will need to contact Computershare directly by phone or post using the details found above.

"},{"question":"How do I notify a change of name?","answer":"

To update your name, an instruction should be sent in writing to Computershare at the address above or by using a change of name form which can be found in the downloadable forms section for GSK at Investor Centre Printable Forms (computershare.com). All applications to change a registered name need to be accompanied by supporting documentation. For proof of marriage, we require either the original or an official copy of the Marriage Certificate. For all other documents, we require either the original or a certified copy.

"},{"question":"I have lost my share certificate. What should I do?","answer":"

You will need to contact Computershare, who will place a restriction on the lost certificate to prevent fraudulent use. A new certificate can be issued, which is done by completing and returning a Letter of Indemnity. There is a cost to Computershare in issuing a replacement certificate, and so there may be a fee charged for this process. You will need to wait for a replacement certificate in order to transfer or sell your shares.

"},{"question":"How do I obtain a copy of a share certificate and other shareholder documents?","answer":"

It is not possible to issue a copy of a share certificate. If you have lost your share certificate, please contact Computershare who will follow the process for a lost certificate (shown above). Other shareholder documents can be obtained by logging into your Investor Centre account or contacting Computershare.

"},{"question":"How can I find out the balance of my shareholdings?","answer":"

Shareholding balance can be found by contacting Computershare via the details on the Investors contact details page. Alternatively, registering an Investor Centre account enables you to access the balance of your holdings online by logging onto your account – details on setting up a portfolio can be found above.

"},{"question":"How can I avoid receiving multiple copies of shareholder circulars?","answer":"

This is likely to have occurred because Computershare is holding two (or more) accounts for you on the share register. If you would like to merge shareholdings registered in your name into a single holding, please provide Computershare with a written request, signed by all the registered holders or legally appointed representatives.

\n

You may have a preference as to which holding you would like the shares to be merged. If so, please inform Computershare by confirming the Shareholder Reference Number (SRN). This is an 11-digit number which can be found on your share certificate or on any previous correspondence we have sent you. There is no need to send Computershare your share certificates, as these will remain valid.

"},{"question":"How can I consolidate my share certificates?","answer":"

If your certificated holding in GSK is represented by several share certificates you may wish to have these replaced by one consolidated share certificate. You should send your certificates (preferably by courier or recorded delivery to minimise them getting lost in the post) with a letter of instruction to Computershare.

"}]},{"type":"rich-text","text":"

Please note that the answers that refer to our registrar, Computershare, are only relevant to those shareholders who hold GSK shares directly on the Ordinary Register with Computershare, or through GSK’s Corporate Sponsored Nominee service. If you hold your shares via your broker or through a nominee service, please contact the bank or stockbroker with whom you hold the shares to obtain guidance.

\n

 

","useGreyBackground":false,"fullWidth":false},{"type":"anchor","menuTitle":"ADR Holders","anchorName":"ADRHolders","nestedModule":{"type":"spacer","label":""}},{"type":"faqs","sectionHeading":"ADR Holders FAQs","collapseAllText":"Close all","expandAllText":"Expand all","questions":[{"question":"How can I buy or sell GSK ADRs?","answer":"

GSK’s depositary bank, JPMorgan Chase Bank N.A. (“JPMorgan”), operates a Global Invest Direct programme which allows first time and existing investors to purchase and/or sell ADRs. For further details and to obtain an enrolment pack, please visit www.shareowneronline.com.

\n

Alternatively, please contact your bank or stock broker who should be able to advise you on how to buy GSK ADRs.

"},{"question":"What is the difference between ADRs and ADSs?","answer":"

An American Depository Receipt (ADR) is issued by a depository bank (JPMorgan in GSK’s case), and is used to represent a specific number of shares of a non-US company traded on a US stock exchange. This allows non-US companies to make their shares available outside their home markets and allows investors in the US and elsewhere to easily invest in companies.

American Depository Shares (ADS) are the actual shares which are traded and, in the case of GSK, listed on the New York Stock Exchange. The terms ADR and ADS are often used interchangeably.

One GSK ADR represents two Ordinary Shares held by JPMorgan.

"},{"question":"How do GSK’s ADRs trade?","answer":"

GSK ADRs are issued by the depositary bank, JPMorgan. The underlying ordinary shares are deposited by a local custodian bank, usually by a broker who has purchased the ordinary shares in the open market. Once issued, GSK ADRs may be traded in the US on the New York Stock Exchange.

When the ADR holder sells, the ADR can either be sold to another investor in the US market or cancelled. In the latter case, the ADR is surrendered to the depositary, and the ordinary shares held with the depositary’s custodian would be released back into the home market (i.e. the UK). A GSK ADR holder is able to request delivery of the underlying GSK Ordinary Shares at any time.

"},{"question":"Who should I contact with queries regarding ADRs?","answer":"

The depositary we use is JPMorgan Chase Bank N.A., whose contact details can be found above.

"},{"question":"Can I vote at the AGM if I hold ADRs?","answer":"

Holders of GSK ADRs are entitled to instruct JPMorgan as to how to vote in relation to their shareholding at the respective Annual General Meetings or General Meetings. The voting rights are in relation to the number of GSK Ordinary Shares represented by the respective ADRs. If you choose not to instruct JPM, your shares will not be voted.

"},{"question":"How do I obtain a copy of shareholder documents?","answer":"

Paper copies of shareholder documents, such as Annual Reports, can be obtained by contacting JPMorgan, directly. Their contact details can be found above. GSK also makes soft copies of most documents, which can be found under ‘Investors – Corporate Reporting’ on our website. 

"},{"question":"How are the dividend payments on ADRs calculated, and what currency are they paid in?","answer":"

ADR dividends are paid in US dollars. The dividend amount paid on ADRs is calculated by converting the dividend amount in pounds sterling to US dollars, using the exchange rate as at close of business two days prior to the payment date. Please note that the US dividend is also subject to a dividend fee of $0.0075 per ADR. 

\n

(The US dollar dividend amount received is likely to differ from the US dollar determining rate announced in the quarterly results due to the currency fluctuations between the date the dividend is declared and two days before the payment date).

"},{"question":"Why does GSK not pay dividends on ADRs in the US dollar determining rate?","answer":"

The ADR depositary is entitled to receive dividends in pounds sterling, which is the currency in which GSK's dividends are declared. Payment in the US dollar determining rate would expose GSK to foreign currency fluctuations arising from movements between ADRs and share registers.

"},{"question":"Is there a dividend reinvestment plan for ADR holders?","answer":"

JPMorgan provides a Global Invest Direct programme, a direct ADS dividend reinvestment plan for ADR holders. For details on how to enrol please visit www.shareowneronline.com  or call the above helpline number to obtain an enrolment pack.

"}]},{"type":"anchor","menuTitle":"Dividend","anchorName":"Dividend","nestedModule":{"type":"spacer","label":""}},{"type":"faqs","sectionHeading":"Dividend FAQs","collapseAllText":"Close all","expandAllText":"Expand all","questions":[{"question":"Where can I find information about GSK’s dividend policy?","answer":"

The company pays dividends quarterly to shareholders who are named on the register on the “record date”. The dividend rate is announced with the quarterly financial results announcements and is determined in pounds sterling.

\n

Historical dividend information can be found on the GSK website under Dividend calculators.

\n

 

"},{"question":"What is the “ex-dividend” date?","answer":"

The ex-dividend date marks the first day when buyers of shares are not entitled to the previously announced dividend. Before this date, shares are said to be ‘cum-dividend’: if you buy shares during this period, you are entitled to the dividend which has just been announced. However, if you purchase shares on or after the ex-dividend date you are not entitled to the pending dividend – the previous owner of the shares is.

"},{"question":"What is the “record date”?","answer":"

The record date is exactly one business day after the ex-dividend date. On this date, the registrar will view the share register and determine who will receive dividends by confirming who is recorded on the register on this date. If you buy shares on the ex-dividend date, you will not appear on the register until after the record date, so will not receive the most recent dividend payment.

"},{"question":"How do I calculate dividend payments?","answer":"

A dividend calculator can be found on the GSK website Dividend calculators.

To calculate, enter the number of Ordinary shares or ADRs owned when dividend was paid. This page also provides quarterly dividend rates since 2001.

\n

 

"},{"question":"How does the Dividend Reinvestment Plan (DRIP) work?","answer":"

The GSK Dividend Reinvestment Plan (DRIP) is a service offered by Computershare in which you can use your cash dividends to buy more shares in GSK. As an alternative to the dividend payment, your cash will be used to buy additional shares. The DRIP is a convenient, easy and cost-effective way to build your shareholding.

\n

Please note that a commission charge of 1 per cent of the value of the shares purchased will be charged by Computershare, and purchases will also be liable to stamp duty at a rate of 0.5 per cent of the value of the shares purchased.

\n

To apply for the GSK DRIP, call +44 (0)370 707 1595, download a DRIP form from the printable forms section for GSK at Investor Centre Printable Forms (computershare.com), or in your Investor Centre account.

"},{"question":"Can I elect to receive my dividends abroad in currencies other than pounds sterling?","answer":"

Computershare have an International Funds service in place, through which they can send dividends to overseas bank accounts. If you need to update or add a payment instruction to your shareholding, the most secure approach is to register with the Investor Centre.

"},{"question":"What do I do if I find an out-of-date cheque?","answer":"

If you find a dividend cheque which is now out-of-date, you can contact Computershare to arrange for your uncashed dividends to be paid directly into a nominated bank or building society account.

"}]},{"type":"rich-text","text":"

Please note that the answers that refer to our registrar, Computershare, are only relevant to those shareholders who hold GSK shares directly on the Ordinary Register with Computershare, or through GSK’s Corporate Sponsored Nominee service. If you hold your shares via your broker or through a nominee service, please contact the bank or stockbroker with whom you hold the shares to obtain guidance.

","useGreyBackground":false,"fullWidth":false},{"type":"anchor","menuTitle":"Mandated Direct Credit","anchorName":"MandatedDirectCredit","nestedModule":{"type":"spacer","label":""}},{"type":"faqs","sectionHeading":"Mandated Direct Credit FAQs","collapseAllText":"Close all","expandAllText":"Expand all","questions":[{"question":"Why did GSK make this change?","answer":"

Receiving dividends by direct credit rather than cheque is a more efficient, secure and environmentally friendly method of payment. It is also cost effective for shareholders as failure to cash cheques before the expiration date may incur cheque reissue fees.

"},{"question":"When did GSK stop sending cheques?","answer":"

January 2020 was the last dividend payment for which you were able to receive a cheque. From April 2020 any monies payable in connection with your shares will only be paid by direct credit.

"},{"question":"What if I didn't provide my bank or building society account details?","answer":"

If you do not provide this information, you will still receive an annual dividend statement; however, you will not receive the money until your bank details are received, after which payment will be credited to your account as soon as possible. Your dividends will not accrue interest while they are being held for you and there will be a fee for Computershare to reissue payments.

"},{"question":"What is direct credit?","answer":"

Direct credit is a commonly used means of payment whereby funds are transferred directly into the recipient’s bank account, rather than by providing a cheque that must subsequently be cashed. Direct credit is a more secure method of payment than cheques. It is used by most large organisations to pay, for example, employees’ salaries.

"},{"question":"How much does direct credit cost?","answer":"

There is no fee charged by GSK or Computershare for this service.

"},{"question":"What type of account can I nominate?","answer":"

You can nominate any UK bank or building society account in your name.

"},{"question":"What if I want to change my nominated account?","answer":"

By registering for an Investor Centre holding, you can manage many aspects of your shareholding online, including updating your bank details. If you are a sole shareholder, you can also update your bank details by calling Computershare, our registrar.

"},{"question":"When will I receive my dividend payment?","answer":"

Dividends will be paid into your nominated bank or building society account as cleared funds on the dividend payment date.

"},{"question":"How will I know that my dividend has been paid?","answer":"

If you register for electronic communications using the Computershare Investor Centre - UK, you will be sent an electronic notification on the day the dividend is paid. If you are not registered, you will receive an annual consolidated dividend statement by post setting out details of all dividends paid to you in the previous twelve months. These statements are currently sent out in January each year.

"},{"question":"Can I receive a dividend statement on the day the dividend is paid?","answer":"

If you do not want to register for electronic communications or receive an annual consolidated dividend statement by post in January each year, then please contact Computershare to request individual dividend statements. These statements will be posted out by second class two days before each dividend payment date so that you receive it on the day the dividend is paid into your bank/building society account.

"},{"question":"How do I provide the registrar with my UK bank or building society account details?","answer":"

To set up direct dividend payments, log in to your Investor Centre account and enter your bank details. Please visit the Investor Centre for details on how to register.

\n

Alternatively, you can contact Computershare directly. Their contact details can be found on the Investors contact details page.

"},{"question":"Can I reinvest my dividends instead?","answer":"

Instead of receiving dividend payments into your bank or building society account, you may wish to build up your shareholding in GSK by using your dividends to purchase further GSK shares. The GSK Dividend Reinvestment Programme (‘DRIP’) is a convenient, easy and cost-effective way to do this. Visit Dividend Reinvestment Plan for more information and a DRIP application form.

\n

Please note: If you are not eligible to join the DRIP, or you revoke your DRIP instruction, you will need to provide your bank or building society account details in order for future dividends to be paid to you.

"},{"question":"What is the Computershare International Funds Transfer Service?","answer":"

If you do not have a UK bank or building society account, you may be able to arrange for payments to be converted and paid in your local currency using the Computershare International Funds Transfer. This service pays in 11 currencies to over 200 different countries. To register for fast and secure payments internationally please visit the Investor Centre.

"},{"question":"What gives GSK the authority to remove dividend cheques?","answer":"

The decision to pay dividends by direct credit, rather than cheque, has been taken to increase the security of payments, decrease costs and reduce our impact on the environment. Under the company’s articles of association, which were approved by shareholders at the 2018 Annual General Meeting, the directors have authority to determine the method by which the company’s dividends are paid, including by direct credit.

\n

Annual General Meeting Archive

"}]},{"type":"spacer","label":""},{"type":"varied-signpost-grid","title":"You might also like","layoutPattern":4,"pages":[{"title":"Our ADR programme","content":"GSK trades in the US on the New York Stock Exchange under the symbol GSK and has an established ADR programme with J.P. Morgan Chase Bank","image":{"src":"/media/ixmprvva/gsk_texture_fluid_01_a_cmyk_websize.jpg?width=427&height=533&format=webp&quality=100&v=1dba2ec2227b210","alt":"Texture fluid graphic","darkModeSrc":"/media/ixmprvva/gsk_texture_fluid_01_a_cmyk_websize.jpg?width=427&height=533&format=webp&quality=50&v=1dba2ec2227b210"},"link":{"text":"ADR Programme","href":"/en-gb/investors/shareholder-information/adr-programme/","openInNewWindowText":null}},{"title":"Corporate sponsored nominee service","content":"The GSK corporate sponsored nominee service is a convenient way to manage your GSK shares without a share certificate","image":{"src":"/media/db2ffgpt/gsk_texture_fluid_01_e_1920x1080_rgb.png?width=427&height=533&format=webp&quality=100&v=1dba2ebd85205f0","alt":"Texture fluid graphic","darkModeSrc":"/media/db2ffgpt/gsk_texture_fluid_01_e_1920x1080_rgb.png?width=427&height=533&format=webp&quality=50&v=1dba2ebd85205f0"},"link":{"text":"Corporate sponsored nominee service","href":"/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","openInNewWindowText":null}},{"title":"Asset reunification - Georgeson ","content":"GSK has launched a tracing programme in partnership with Georgeson with the aim of reuniting 'lost' shareholders with unclaimed entitlements","image":{"src":"/media/yanaabf2/gsk_texture_fluid_02_c_cmyk_web-size.jpg?width=427&height=533&format=webp&quality=100&v=1dba2ec22345c40","alt":"Texture fluid graphic","darkModeSrc":"/media/yanaabf2/gsk_texture_fluid_02_c_cmyk_web-size.jpg?width=427&height=533&format=webp&quality=50&v=1dba2ec22345c40"},"link":{"text":"Asset reunification - Georgeson","href":"/en-gb/investors/shareholder-information/asset-reunification-georgeson/","openInNewWindowText":null}}],"hidePageDescription":false,"useGreyBackground":false}]}